The British Journal of Cardiology

AUGUST 14, 2024

Faculty member Affiliation Professor Amitava Banerjee Professor of Clinical Data Science, Institute of Health Informatics, University College London; Consultant Cardiologist, University College London Hospitals and Barts Health NHS Trust Professor Sir Mark Caulfield Professor of Clinical Pharmacology, Queen Mary Un.

Cardiovascular Disease 52

Cardiovascular Disease Patient Care Innovation Pharmacology 52

HeartRhythm

APRIL 30, 2024

This innovation bottleneck may be attributed to the lack of a preclinical model that not only recapitulates human disease but is also suitable for empiric drug discovery.

Pharmacology 40

Pharmacology Defibrillator Innovation Arrhythmia 40

DAIC

FEBRUARY 27, 2024

Bernard's Heart & Vascular Center , Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrial fibrillation (NVAF) treatment. The prospective, randomized, controlled, multicenter, open-label pivotal clinical study aims to enroll 1,500 patients across up to 100 sites in the United States. 

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Frontiers in Cardiovascular Medicine

JUNE 3, 2024

Despite extensive efforts to develop pharmacological treatments, there is currently no effective agent to prevent aneurysm growth and rupture. Abdominal aortic aneurysm (AAA) is a significant source of mortality worldwide and carries a mortality of greater than 80% after rupture.

Aneurysm 69

Aneurysm Aortic Pharmacology Innovation 69

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2023

Sodium-glucose cotransporter 2 (SGLT2) inhibitors represent one of the most important pharmacological innovations in the field of Cardiology of the last decades, having shown significant outcome improvement in all the heart failure (HF) spectrum. However, cost-effectiveness considerations should be made.

Heart Failure 40

Heart Failure Pharmacology Innovation Outcomes 40

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. The Role of Research and Innovation Ongoing research in AFib is uncovering new insights into the pathophysiology of the condition and leading to the development of novel therapies.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

DAIC

APRIL 3, 2024

The “Pharmacology Program” will cover hot topics in cardiovascular medicine that are key issues that pharmacists, as well as other health care team members, face in managing complex patients. Each session is interactive and includes knowledge check-ins and dedicated time for discussion. 24 news here.

Education 105

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology 105